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Background: Parinari curatellifolia and Combretum zeyheri are medicinal plants used in Zimbabwe and other
Southern African countries for stomach ailments, fever, body aches, wound healing, cancer and tuberculosis.
Glutathione transferases (GSTs) are mammalian enzymes that play a significant role in the detoxification and
metabolism of many xenobiotic and endogenous compounds and as such can interact with many exogenous
compounds including herbal medicines.
The effects of Parinari curatellifolia and Combretum zeyheri leaf extracts on glutathione transferases of male
Sprague–Dawley rats were investigated in vivo and in vitro after oral administration of either leaf ethanol or water
extracts of each plant.
Methods: For Parinari curatellifolia, 18 male Sprague-Dawley rats were administered with 0, 500 and 1000 mg/kg
body weight of the leaf extracts in corn oil or saline. Animals were sacrificed after 96 h and the kidney and liver
samples were removed and used to prepare the cytosolic fractions. GST activity was determined using 1-chloro-2,
4-dinitrobezene. For Combretum zeyheri, twenty four male Sprague–Dawley rats were randomly divided into two
groups. These two groups were further divided into three groups of four animals each. They were given either the
aqueous or ethanol extract at doses of C. zeyheri at 0, 50 mg/kg body weight and 200 mg/kg body weight. The
extracts were administered orally by oral gavage for four consecutive days and the rats were sacrificed by cervical
dislocation on the fifth day.
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Results: In animals administered with C. zeyheri, GST activity was significantly increased by the 200 mg/kg aqueous
extract in the kidneys and livers in vivo whilst the ethanolic extract at 200 mg/kg decreased enzyme activity
significantly both organs. Both the ethanol and aqueous extracts inhibited GST activity in vitro with the ethanol
extract being more potent inhibitor than ethacrynic acid, a standard GST inhibitor. The increased GST activity
in vivo and versus inhibition in vitro suggests that metabolites may be responsible for the effects observed in vivo.
For P. curatellifolia, a dose-dependent decrease in GST activity was observed in vivo for the animals given the
aqueous extract but no changes were observed with the ethanol extract. There was a concentration-dependent
inhibition of cytosolic GSTs when P. curatellifolia leaf extracts in vitro. The ethanol extract of P. curatellifolia exhibited
GST-inhibitory activity in the liver with an IC50 value of 12 μg/mL and for ethacrynic acid, the IC50 was found to be
10 μg/mL. This showed that this extract was a potent inhibitor of GSTs in vitro.
Conclusions: C. zeyheri had an inductive effect on GST activity when administered in aqueous solution but
inhibited GST in vitro whilst P. curatellifolia inhibited GST activity in vivo. Induction of GSTs would be cytoprotective
against the toxic effects electrophilic chemicals. Since GSTs are responsible for the synthesis of prostaglandins, the
inhibition of GST activity of by these two plants in vivo maybe one of the reasons that makes the plants important
for use in the treatment pain and fever in ethnopharmacology.
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Glutathione S-transferases (GSTs) catalyze the nucleo-
philic attack of the tripeptide glutathione to electrophillic
substrates, resulting in addition or substitution reactions
depending on the nature of the substrate [1]. Glutathione
conjugation is the first step in the mercapturic acid path-
way that leads to the elimination of toxic compounds [2].
GSTs have been found to comprise up to 10 % of the
total hepatocellular protein, assuring efficient enzymatic
conjugation of glutathione to reactive electrophiles [3].
The high concentration of GSTs also provides a reservoir
of intracellular binding sites that facilitates noncovalent
and sometimes covalent interactions with compounds that
are not substrates for glutathione conjugation [4]. The
most commonly used co-substrate for GST is a synthetic
chemical 1-chloro-2, 4-dinitrobenzene (CDNB) [2] and
spectrophotometric assays utilising this substrate are com-
monly used to report GST activity [5]. Due to their high
abundance in the liver, GSTs may be interact with exogen-
ous compounds including natural plant products [6].
GSTs have endogenous functions that include the syn-
thesis of prostaglandins (PG) [7]. PGD2 is produced as a
major prostaglandin in a variety of tissues and is produced
by two distinct prostaglandin D synthases (PGDS) that are
hematopoietic (H-PGDS) and lipocallin (L-PGDS). How-
ever, production of PGD2 in the peripheral tissues and in
immune and inflammatory cells is mainly catalysed by
H-PGDS, which is a cytosolic, glutathione-dependent
enzyme of the sigma class glutathione-S-transferase
(GST) family [8]. The GSH-dependent conversion of
prostaglandin PGH2 to either PGD2 or PGE2 are
other examples of isomerisation reactions in which
GSTs are involved [9]. These reactions do not neces-
sarily involve GST sigma as they involve the mPGES-1, a membrane-associated enzyme with glutathione-
dependent activity, and its expression is highly indu-
cible in response to inflammatory stimuli. c-PGES is
also a glutathione-dependent enzyme, and is
expressed in the cytosol of a wide variety of tissues
and cells [10].
Rural households in Zimbabwe rely largely on trad-
itional medicines and with AIDS and a declining econ-
omy, there has been an upsurge in the number of people
using herbal medicines [11]. Combretum zeyheri is a
large-fruited bush willow that is found from Congo and
Tanzania southwards to South West Africa, Zimbabwe,
Botswana, the Transvaal and Natal [12]. The leaves,
roots and stem bark of C. zeyheri are used medicinally.
C. zeyheri has been used for reducing symptoms associ-
ated with coughs, diarrhea, and cancer [13, 14]. Rheuma-
tism and joint pain is reportedly treated with crushed
leaves of C. zeyheri [15]. Decoctions of finely ground
leaves are reported to be very effective for the treatment
of eye inflammation and conjunctivitis. Leaves are
pounded with oil and rubbed in for the treatment of back
pain or macerated together with roots for the same pur-
pose [16]. The roots and stem bark of C. zeyheri are
also used for medicinal purposes. Hot water extracts
and infusions of the roots and stem bark are added
to porridge to treat diarrhea, dysentery and vomiting
[17]. Roots are chewed for the treatment of schisto-
somiasis [17]. Fruits of Combretum species are, how-
ever, considered poisonous in African traditional
medicine [18]. The plant has antibacterial activity
against. Staphylococcus aureus and antifungal activity
against Candida albicans [19].
Parinari curatellifolia belongs to the family Chrysoba-
lanaceae (mobola family/coco plum family) [20].
Gweshelo et al. BMC Complementary and Alternative Medicine  (2016) 16:238 Page 3 of 15Parinari curatellifolia has various uses in ethnomedicine
[21]. Parinari curatellifolia had been used in Zimbabwe
for constipation, toothaches and for wound healing pur-
poses [11, 22]. The fruit extracts are used to heal inflam-
mation and anemia [23]. P. curatellifolia is also used in
the treatment of pneumonia, fever, inflammatory condi-
tions and dressings of fractures and dislocations [21]. In
Zimbabwe, the leaf extracts and bark have been used as
for treatment of skin rashes, tuberculosis, chronic diar-
rhea, herpes zoster, and herpes simplex [24, 25]. P. cura-
tellifolia is also used to treat malaria, wounds, typhoid,
fever and has been reported to have antiplasmodic effects
[26]. P. curatellifolia leaf extracts also demonstrated
in vitro antimicrobial activities against two model non-
pathogenic species: Mycobacterium aurum and Coryne-
bacterium glutamicum [25] and against Corynebacterium
ulceran, E. coli, and Candida albicans [26].
Approximately 49 % of 877 small molecules that were
introduced as new pharmaceuticals between 1981 and
2002 by new chemicals entities were either natural prod-
ucts or semi-synthetic analogs or synthetic products
based on natural product models [25, 27, 28]. The most
vital contributions herbal medicines have made in devel-
oping countries are reducing mortality and morbidity.
The main reason for their widespread use is because
they are cheap to acquire and most have less toxic ef-
fects as compared to the non-herbal medicines and are
perceived as safe [29]. Currently efforts are being done
to develop new in vitro bench-top bioassays which allow
for the practical applications of bioassay-guided fraction-
ations of crude extracts of plants, marine organisms, and
microbes in order to discover new pharmaceuticals [30].
One of these aspects is to discover new naturally occur-
ring enzyme inhibitors. There is evidence that adminis-
tration or consumption of plant-based products can
modulate the levels of glutathione transferases in vivo
[31]. Epiglottitis, an inflammation of the epiglottis was
treated by leaf extracts of Parinari curatellifolia [32]. In-
flammation is caused by production of prostaglandins
and any extract that would have curative effects is likely
going to interact with enzymes that produce prostaglan-
dins. Atawodi et al., [33] investigated the effects of Pari-
nari curatellifolia root extracts on rats. Their results
showed that the plant extracts had significant antioxi-
dant and hepatoprotective effects on acute and chronic
liver injuries. Parinari curatellifolia flavonoids were also
shown to protect rats from acetaminophen–induced
hepatic necrosis [23, 34]. The metabolism of acetamino-
phen produces a reactive quinone metabolite that is de-
toxified through a glutathione transferase-dependent
reaction [4]. It has also been shown that extracts from
C. zeyheri, P. curatellifolia and C. platypetalum have
significant antioxidant properties through their abilities
to scavenge the nitrite radical in vitro [35]. Chemicalswith antioxidant properties have the capacity to induce
glutathione transferases in vitro and in vivo through the
bZIP transcription factor (Nrf2) and the antioxidant
response element (ARE) [36, 37]. Moyo et al., [38] showed
that another Combretum species, Combretum molle inhib-
ited human recombinant hematopoietic prostaglandin D2
synthase (GST sigma) in vitro, an enzyme that is involved
in the synthesis of prostaglandin D2. Combretum leprosum-
derived triterpenes have been shown to have anti-
inflammatory effects in mice [39]. Administration of Com-
bretum zeyheri extracts to rats and subsequent isolation of
metabolites, showed that the rat liver metabolites could
inhibit the growth of microorganisms [40]. Using human
recombinant hematopoietic prostaglandin D2 synthase
(GST sigma), we have also shown that the Parinari curatel-
lifolia leaf extract was the most potent plant extract (IC50 =
3.8 μg/ml) to inhibit this enzyme in vitro [41]. The same
study also showed that Combretum zeyheri methanol and
water extract inhibited this enzyme in vitro with IC50s of 8
and 29 μg/ml respectively. Based on these studies, the
effects of Combretum zeyheri or Parinari curatellifolia
extract in an animal model of glutathione transferase activ-
ity was, therefore, warranted. The main objectives of this
study was to investigate the effects of P. curatellifolia and
C. zeyheri ethanol and aqueous leaf extracts on




Analytical reagent grade solvents and chemicals of
greater than 99 % purity were purchased from Sigma-
Aldrich (Steinheim, Germany). The reagents and chemi-
cals used included sodium chloride, trizma base, ethyl-
ene diamine tetraacetic acid (EDTA), sodium hydroxide,
L-glutathione (reduced), disodium monophosphate, so-
dium diphosphate, 1 chloro-2, 4 dinitrobenzene (CDNB),
ethacrynic acid, sodium carbonate, copper sulphate, po-
tassium sodium tartrate, bovine serum albumin (BSA),
Folin and Ciocalteu’s phenol reagent, hydrochloric acid,
potassium chloride, corn oil (EEC No 232-281-2), analyt-
ical grade ethanol and potassium phosphate dibasic
trihydrate.
Plant collection
Fresh leaves of P. curatellifolia were obtained from
Centenary (Mashonaland Central Province 16.8000°S,
31.1167°E) whilst those of C. zeyheri were obtained
from Norton (Mashonaland West Province 17.8833°S,
30.7000°E). The identities of the plants were authenticated
by a botanist, Mr. Christopher Chapano, at the National
Botanic and Herbarium Garden, Harare, Zimbabwe. Herb-
arium samples C6E7 and N6E7, were kept at the National
Botanic and Herbarium Garden and the Department of
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washed with tap water and oven-dried at 50 °C for
three days until they were crisp. The leaves were then
ground to fine powder using a laboratory blender
(Cole Parmer, Vernon Hills, USA).Preparation of plant extracts
A volume of 100 mls of analytic reagent grade etha-
nol was added to 25 g of powdered plant extract. The
resultant solution was placed in a rotary incubator
(SANYO Gallenkamp PLC, UK) for 6 h. The agitation
rate was kept at 150 rev/min. The solution was fil-
tered through a Whatman no 1. filter paper and the
procedure was repeated twice. The solution was dried
over a fan in open petri dishes for three days. The
sample was scraped off with a spatula, weighed and
stored at 25 °C for future use. For the aqueous
extract, dried leaf powder for each plant of 25 g was
boiled in 100 mls of water for 2 h. Water was
drained and the residue boiled for a second time
under the same conditions. The solution was filtered
through a Whatman No. 1 filter paper and the pro-
cedure was repeated twice. Finally the extract was
dried over a fan. The sample was scraped off with a
spatula and transferred to a mortar. The sample was
ground with a pestle and mortar until a fine brown
powder was formed. The extract was then weighed
and stored at 25 °C until when required.Experimental animals
The study was approved by the Joint Parirenyatwa
Hospital and College of Health Sciences Research
Ethics Committee (JREC ref 185/11, Harare,
Zimbabwe). Fifty four male Sprague–Dawley rats
weighing (90–160 g) were purchased from the
Animal House of the University of Zimbabwe. Prior
to oral administration with the plant extracts, rats
were housed in steel cages five per cage for the aque-
ous leaf extract treatment and four per cage [42] for
the ethanol leaf extract treatment with a bedding of
wood shaving that was changed when necessary. The
rats were fed with certified food pellets rodent com-
broids, (National foods (PVT), Ltd., Harare,
Zimbabwe) ad libitum and allowed free access to tap
water. The animal room was maintained in an envir-
onmentally controlled facility with an ambient
temperature of 25 °C, photoperiod of 12 h light–dark
cycle (0600–1800). Animals were maintained and
handled according to the recommendations of the
good laboratory practice and animal handling (NIH)
guidance for the care and use of laboratory animals,
Publication No. 85–23, 1985.Administration of extracts of Parinari curatellifolia and
Combretum zeyheri to rats
Ethanol leaf extracts were dissolved in corn oil to yield
solutions for delivery of 50 and 100 mg/kg body weight
(1/140
th and 1/70th of the LD50 respectively). These con-
centrations were chosen to include the doses used in
other studies [43] such that dose-dependent parameters
could be inferred. Corn oil was the vehicle and was used
as a control so that Sprague–Dawley rats received an
equivalent volume to those given P. curatellifolia ethanol
leaf extracts. A solution of 0.9 % w/v normal saline was
used as a control for the water extracts from the plants.
Solutions were prepared by dissolving P. curatellifolia
aqueous leaf extracts in 0.9 % normal saline and these
were for delivery of 50 and 100 mg/kg body weight.
Expression of xenobiotic metabolizing enzymes such as
glutathione transferases can be hormonally regulated [3]
and so to rule out the interference from hormonal
effects, only male animals were used. Male rats were
separated into three groups: 100 mg/kg body weight,
50 mg/kg body weight and corn oil / normal saline. Each
group consisted of 5 animals administered with the
aqueous extract of P. curatellifolia and 4 animals admin-
istered with the ethanol extract. The body weights were
recorded daily to allow for the appropriate dose of P.
curatellifolia leaf extract solutions to be administered.
All rats were administered with the plant extracts
through gastric gavage (6.7 ml/kg) at 24- h intervals to
allow for maximal excretion of the previous dose prior
to injection. Three days following oral administration of
the extracts and control solutions, the rats were starved
overnight the body weight body weight determined. The
rats were sacrificed by cervical dislocation.
For C. zeyheri, male Sprague–Dawley rats were first
randomly divided into two groups of twelve, one group
as given the ethanol extract whilst the other was given
the aqueous extract. Each of the twelve rats were then
further divided into three groups, each group containing
four animals. The first group was given the drug vehicle
alone, the second group was given the 50 mg/kg body
weight (B/W) dose and the last group was given the
200 mg/kg BW dose. Administration of these solutions
was done by oral gavage for four consecutive days. The
weight of each animal was determined before being
given the appropriate dose.
Preparation of cytosolic and microsomal fractions from
rat tissue
Throughout the procedure tissue fractions were kept
cold (0–4 °C) by using pre-cooled homogenization
medium (50 mM Tris–HCl containing 0.154 M KCl)
and keeping centrifuge rotors, tissue homogenizer, meas-
uring cylinders, beakers and centrifuge tubes in ice. Ex-
cess blood was removed from the liver by perfusing the
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LKB pump P-1 (Pharmacia, Uppsala, Sweden) at a flow
rate of 50 ml/h through the still beating heart then gen-
tly blotting with dry tissue paper. Perfusion was per-
formed in situ to remove blood. The livers and kidneys
were removed and blotted dry. The liver or kidney sam-
ples were, weighed, wet mass recorded and livers quickly
transferred to a homogenizing vessel, which was kept,
on ice. Homogenizing medium 50 mM Tris–HCl pH 7.4
containing 154 mM KCl was added to each sample
(5 ml/g of liver). The liver or kidney samples were cut
into suitable pieces and homogenized with a motor driven
Potter-Elvehjem homogenizer type R2R (Heidolph Elektro
KG., Kelheim, Germany). The homogenates were decanted
into measuring cylinders and the final homogenates ad-
justed to approximately 0.25 g fresh tissue/ml (25 % hom-
ogenate). The final volume was recorded and “parafilm TM”
(Sigma-Aldrich Co., Steinheim, Germany) was added to
cover. Mixing was carried gently and a desired amount
transferred to pre-cooled centrifuge tubes. The tubes were
capped and a post mitochondria supernatant fraction pre-
pared by centrifugation at 10000 x g (7500 rev/min) for
20 min at 2–4 °C in a Beckman Optima LE-80 k ultracen-
trifuge (Beckman Instruments Inc., California, USA). The
tubes were removed and the supernatant decanted in pre-
cooled measuring cylinders. Centrifuging was then done at
105000 x g (35000 rev/min) in a Beckman Optima LE-80 k
ultracentrifuge (Beckman instruments Inc., California,
USA) for an hour to get the microsomal pellet and
supernatant fraction (cytosol GSTs). The supernatant
was dispensed into 1.5 ml labeled microtubes and
stored at −35 °C. Protein content in the liver and kid-
ney cytosolic fractions was determined using the
Lowry method [44].Determination of GST activity
The total GST activity in cell supernatants was measured
spectrophotometrically using final concentrations of
1 mM 1-chloro-2,4-dinitrobenzene (CDNB) and 1 mM
glutathione, as substrates in 0.1 M potassium phosphate
buffer pH 6.5, and GST (0.125 mg/ml protein) [2]. Cyto-
solic glutathione transferases activities were assessed
using 0.5 mg/ml and 2 mg/ml enzyme dilutions for the
liver and kidney samples respectively. All GST mediated
conjugation reactions were carried out at a temperature
of 30 °C using a microplate incubator (Jitterbug, 130000,
Boekel Industries, Philadelphia, USA). GST mediated
conjugation of 1-chloro-2, 4- dinitrobenzene (CDNB) to
glutathione (GSH) was measured using 96-well microti-
tre plates in a microplate reader (Biokinetics reader EL
340 microplate, Highland Park, 998, Winsooki, VT,
USA). The reaction was initiated by the addition of
CDNB solution to each well.In vivo enzyme assay
For the in vivo study, the cytosolic fractions from treated
animals were used without the addition of the plant
extracts to the reaction mixture. The in vivo enzyme
assay incubation mixtures (300 μL) contained 135 or
185 mls 0.1 M potassium phosphate buffer pH 6.5,
15 μL 20 mM CDNB, 100 μL 3 mM GSH, and 50 μL
GST enzymes. Potassium phosphate buffer was added to
each well followed by cytosolic solution and glutathione.
The plate was allowed mixed for a minimum of 5 min at
30 °C. The reaction was initiated by the addition of
CDNB solution to each well. After addition of CDNB
the microplates was transferred to the reader. The plate
was read at 5-min intervals for a total of 15 min in a
microplate reader (Biokinetics reader EL 340 microplate,
Highland Park, 998, Winsooki, VT, USA). Graphs of
time against absorbance were generated for each reac-
tion and from these the rates of enzyme activity were
determined.
In vitro enzyme assay
For the in vitro enzyme assay, incubation mixtures
(300 μL) contained 135 or 85 mls 0.1 M potassium phos-
phate buffer pH 6.5, 15 μL 20 mM CDNB, 100 μL 3 mM
GSH, 50 μL plant extracts/ 15 μL ethacrynic acid and
50 μL 2 mg/ml or 0.5 mg/ml GST enzymes. Controls were
run in triplicates (for the aqueous extract control group)
and quadruplicates (for the ethanol extract control group).
Assay buffer was added to each well followed by the cyto-
solic fraction, plant extract (or ETA) solutions and gluta-
thione. The plate components were mixed in shaker for a
minimum of 5 min at 30 °C. The reaction was initiated by
the addition of CDNB solution to each well. After addition
of CDNB, the plate was transferred to the microplate
reader. The plate was read at 5-min intervals for a total of
15 min.
Statistical analysis
Statistically significant differences among the mean
values were determined by one way analysis of variance
(ANOVA). A Dunnet’s posttest was used as post test to
determine which mean values were significantly different
from the control values. All computations were per-
formed using Graph Pad Prism4® software (Version 4.0,
Graph pad Software Inc, San Diego, USA).
Results
Effects of the plant extracts on physiological parameters
Administration of the methanol or aqueous extracts of
P. curatellifolia did not have an effect on the weights of
the animals, on organ to body weight ratios (data not
shown) but had an effect on the protein content from
the liver (Fig. 1a). The water extract increased the pro-

































Fig. 1 The effects of P. curatellifolia and C. zeyheri leaf extracts on
protein content from rat livers. a. The effects of the ethanolic and
aqueous P. curatellifolia leaf extract on liver protein content. Data are
expressed as the mean ± standard error (n = 5 for water extract and
n = 4 for ethanol extract) b. The effects of the ethanol leaf extract of
C. zeyheri on liver protein content. Data are expressed as the mean
± standard error (n = 4). *P < 0.01
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istration of the ethanol or aqueous extracts of C. zeyheri
did not have an effect on the weights of the animals, on
organ to body weight ratios (data not shown) but produced
a significant change of 162 % in total liver protein quantity
was observed in the animals treated with 200 mg/kg BW
of the C. zeyheri ethanol extract (Fig. 1b).
The effects of P. curatellifolia and C. zeyheri leaf extracts
on GSTs activities in vivo
The effects of P. curatellifolia ethanol and aqueous leaf
extracts on kidney and liver GSTs activities in vivo are
shown in Fig. 2a and b respectively. In the kidneys, the
animals that were administered with the ethanol extract,
showed no significant differences in enzyme activity
between the control and the treated animals. For the an-
imals that were administered with the aqueous extract,
there was a decrease by 20 % in enzyme activity for the
50 mg/kg BW group. In the livers (Fig. 2c and d), the
ethanol extract treated animals, showed no significantdifferences in enzyme activity between the control and
the treated animals. Different activities were noted on
GST activity in the liver and kidneys on animals admin-
istered with aqueous extracts. GST activity was reduced
by 20 % in the kidneys at 50 mg/kg body weight and
28 % and 42 % for the 50 mg/kg body weight and
100 mg/kg body weight in the liver respectively. Consid-
ering rat liver GST activity in the control groups, it was
shown that the enzyme activity for the aqueous extract-
treated group was 167 % higher than that of the ethanol
treated group. Control group comparison shows that the
normal saline treatment resulted in higher enzymatic
activity as compared to the corn oil treatment.
For C. zeyheri (Fig. 3), an increase in GST activity was
observed in the liver and kidney samples from the animals
given 200 mg/kg BW aqueous extract (Fig. 3a and b). The
GST activity increased by 92 % and 400 % for the liver and
kidney samples respectively. The ethanol extract of C. zey-
heri however, had a different effect on the GSTs in vivo.
The 200 mg/kg ethanol extract of C. zeyheri caused a de-
crease in the rat liver and kidney GST activities (Fig. 3c
and d) respectively. The GST activity decreased by 45 %
and 17 % in the liver and kidney samples respectively. It
was also observed that amongst the control animals given
only normal saline, there was higher GST specific activity
in the livers than in the kidneys, whilst the reverse was ob-
served for the control animals given corn oil alone.
The effects of P. curatellifolia leaf extracts on GSTs
activities in vitro
The IC50 values for P. curatellifolia and ethacrynic acid
a standard GST inhibitor, were determined by plotting
the percentage inhibition of GSTs activity versus log
concentration of P. curatellifolia and ethacrynic acid.
The addition of P. curatellifolia leaf extracts to the reac-
tion medium led to a concentration-dependent inhib-
ition of GST activity from in vitro (Fig. 4). In the livers,
the percentage inhibition of GSTs activity varied from
38–100 % for the aqueous extract and 3–96 % for the
ethanol extract. The inhibition of GSTs activities in the
kidneys varied from 36–85 % for the aqueous extract
and 10–100 % for the ethanol extract (Fig. 5). For all the
plant extracts, the IC50 values were determined from
such graphs and are shown in Table 1. All the IC50
values for the plant extracts were higher compared to
those of ETA. The IC50 values for the rat livers treated
with corn oil had lower values as compared to the nor-
mal saline treated group. However, there were no sig-
nificant differences in the IC50 values observed in the
GSTS from kidneys that were exposed to the ethanol
and aqueous extracts. GST activity from the two or-
gans showed that the IC50 value values for GSTs from
the kidneys were higher than the IC50 values of GSTs
from the kidney.












































































Aqueous extracts on rat livers














Fig. 2 a. The effects of P. curatellifolia ethanol and aqueous leaf extracts on kidney GSTs activity in vivo. The enzyme activity was determined
using CDNB as substrate. b. The effects of P. curatellifolia ethanol and aqueous leaf extracts on liver GSTs activity in vivo after 72 h. Data are
expressed as the mean ± standard error (n = 5 for aqueous and n = 4 for ethanol extract treated animals). * P < 0.01
a b
c d
Fig. 3 The effect of different C. zeyheri doses on the activity of GST compared to the respective control groups. a and b show the effects of the
aqueous and ethanol extracts on liver GSTs respectively whilst c and d show the effects of the aqueous and ethanol extracts on kidney GSTs
respectively. A significant change in GST specific activity is indicated by ** (p < 0.01)
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Fig. 4 The IC50 value determination for ethacrynic acid and P. curatellifolia ethanol extracts in liver and kidney samples from corn oil-treated
group. a Percentage inhibition of liver GSTs activity versus log concentration of P. curatellifolia ethanolic extracts. b Percentage inhibition of liver
GSTs activity versus log concentration of ethacrynic acid (ETA). c Percentage inhibition of kidney GSTs activity versus log concentration of P.
curatellifolia ethanolic extracts. d Percentage inhibition of kidney GSTs activity versus log concentration of ETA
a




















































































Fig. 5 The IC50 value determination for ethacrynic acid and P. curatellifolia aqueous extracts in liver and kidney samples from normal saline
treated group. a Percentage inhibition of liver GSTs activity versus log concentration of P. curatellifolia aqueous extracts. b Percentage inhibition
of liver GSTs activity versus log concentration of ETA. c Percentage inhibition of kidney GSTs activity versus log concentration of P. curatellifolia
aqueous extracts. d Percentage inhibition of kidney GSTs activity versus log concentration of ETA
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Table 1 IC50 values for P. curatellifolia, C. zeyheri and ethacrynic
acid determined from direct interactions with GST in vitro. The
IC50 values were determined by reading the concentration at
50 % inhibition from the dose response graphs
Organ Extract IC50 (μg/ml) ETA IC50 (μg/ml)
Parinari curatellifolia
Liver Aqueous 24 6
Liver Ethanol 12 10
Kidney Aqueous 52 7.4
Kidney Ethanol 52 3.7
Combretum zeyheri
Liver Aqueous 68 5.4
Liver Ethanol 1.3 10
Kidney Aqueous 80 10
Kidney Ethanol 1.4 3.1
The IC50 values were obtained from Figs. 4–7. Each of the value was obtained
from thesigmoidal dose–response curves as the concentration of the inhibitor
was increased and are the mean of 4 values
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Inhibition of hepatic and kidney GST activity was ob-
served after exposing cytosolic fractions of control sam-
ples to increasing concentration of the aqueous or
ethanol extracts. C. zeyheri ethanol extract was a more
potent inhibitor of the hepatic GSTs than the aqueous
extract as observed by shown by their IC50 values (Fig. 6
and Table 1). Ethacrynic acid was a more potenta Aqueous extract (Saline-treated)
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Fig. 6 The effect of increasing the concentration of C. zeyheri extract or the
treated with saline or corn oil. The graphs are plots of percentage GST acti
ethacrynic acid. Graph a and b show the effects of different concentrations
GST percentage activity respectively. Graphs c and d show the effects of d
GSTs from the saline and corn oil control groups respectivelyinhibitor of the liver GSTs than the C. zeyheri aqueous
extract whilst the ethanol extract caused inhibition to a
greater extent than ethacrynic acid in vitro. The ethanol
extract also caused greater inhibition of GSTs in the kid-
neys than the aqueous extract. Ethacrynic acid was, how-
ever, a more potent in vitro inhibitor of kidney GSTs
compared to both the aqueous and ethanol C. zeyheri
leaf extracts (Fig. 7 and Table 1).
Discussion
Glutathione transferases play a significant role in the
detoxification and metabolism of many xenobiotic and
endogenous compounds and are over-expressed in some
cancer cells. These enzymes, therefore, contribute to de-
toxification of anticancer drugs, leading to drug resistant
tumours and, thus, their inhibition has been suggested
as an approach to combat GST-induced resistance.
Many plant-derived compounds possess anticancer ac-
tivity and inhibition of GSTs would add to their antitu-
mour potency by preventing drug resistance. Induction
of GSTs in vivo is potentially beneficial in protecting the
cells from electrophillic insult and electrophillic com-
pounds are deficient in paired electrons thus they can
cause diseases such as cancer and neurodegenerative dis-
eases by snatching electrons from macromolecules such
as DNA, and proteins [45]. In addition, GSTs also pro-
tect cells by sequestering compounds through their abil-
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ethacrynic acid on control liver cytosolic samples from the rats
vity against the logarithm of the concentration of the plant extract or
of the plant extracts (saline–treated or corn oil-treated) on rat hepatic





Fig. 7 The effect of increasing the concentration of C. zeyheri extract or the ethacrynic acid on control kidney cytosolic samples from the rats
treated with saline or corn oil. Plots of percentage GST activity versus log concentration of C. zeyheri extracts as well as log concentration of
ethacrynic acid for the effects of C. zeyheri on GST activity in vitro. Graphs a and b show the effects of the aqueous and ethanol extracts on
kidney GSTs respectively whilst C and D show the effects of ethacrynic acid on kidney GSTs from the saline and corn oil control
groups respectively
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reactions may interfere with physiological processes such
as the synthesis of prostaglandin D2 [41].
C. zeyheri aqueous extract caused hepatic (200 mg/kg
dose) and renal (50 mg/kg dose and 200 mg/kg dose) in-
crease in GST activity. Natural active compounds de-
rived from plants, such as flavonone and flavones, have
been shown to increase GST in vivo activity in rat liver
as a result of induction of these enzymes [43]. One of
the major mechanisms of protection against carcinogen-
esis, mutagenesis and other forms of toxicity mediated
by carcinogens is the induction of enzymes involved in
their metabolism particularly the Phase II enzymes such
as the GSTs [5]. Studies have been carried out in which
case other plant extracts of different species caused hep-
atic induction of Phase II enzymes, including the GSTs
[44]. The best known among compounds, which prefer-
entially or selectively induce Phase II enzymes are the
antioxidants [47, 48]. Antioxidants coordinately elevate
GSTs through a common transcriptional activation path-
way controlled by an antioxidant response element. This
process of induction has been extensively studied in the
liver [49]. The mechanism by which C. zeyheri caused an
increase in GST activity is not known. Induction of GSTs
via activation of transcription mechanism may have oc-
curred in the rat liver and kidney tissues since all plants
generally contain secondary metabolites and most ofthese secondary metabolites have been shown to have
antioxidant effects [50].
Traditional healers in Zimbabwe, usually administer C.
zeyheri in aqueous form by suspending the leaves of the
plant in water and administering the extract [11]. The
leaves are usually targeted as they are the easiest parts of
the plant to obtain and they have also been shown in
other plants to contain the highest amounts of second-
ary metabolites. As a result, the in vivo inductive effects
of C.zeyheri observed in the rat tissues might be expected
to occur in other mammalian tissues and if extrapolated
to humans, induction of GSTs can be expected to pre-
dominate. This could result in beneficiary or adverse
effects of C. zeyheri. The beneficiary part would be that,
the C. zeyheri when taken alone would enhance the anti-
oxidant defense mechanisms due to induction of the GSTs
which are involved in the detoxification of reactive oxygen
species [6]. In the body, GST is involved in the detoxifica-
tion of hydrogen peroxide by catalysing its reduction to
non-toxic products [51]. The effects of free radicals, which
play a major role in the pathogenesis of many diseases
including atherosclerosis, ischemic heart disease and
cancer, can be reduced [52]. Since this plant is used medi-
cinally for rheumatism and joint pain [15], the basis of
these uses could be by inhibition of GSTs which through
their action could cause a decrease in the synthesis of
prostaglandins [41].
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tered if C. zeyheri in aqueous form, is simultaneously
taken with a drug that is metabolised by GST. Metabol-
ism of the drug by GST renders the drug more soluble
and enhances its excretion from the body [53]. This
would in turn reduce the therapeutic effects of the drug
or even cause therapeutic failure as the residence time of
the drug in the body is reduced. Such herb-drug interac-
tions are likely to occur as this issue has been a cause
for concern especially in the rural areas where people
use herbal medicines as their primary source of health
care and due to poverty. These people cannot easily ac-
cess conventional medicines regularly and due lack of
knowledge about the possible consequences may take
different kinds of medicines at the same time [54]. En-
couraging these people to take C. zeyheri and conven-
tional medicines separately would greatly benefit these
people and avoid related misfortunes.
Induction of phase II drug metabolising enzymes is
also an important aspect in drug discovery, the ability to
induce GST activity is a property common to many che-
mopreventive agents. The induction of GSTs appears to
be an important mechanism for diminishing carcinogen-
icity. Chemoprevention is one of the most promising
areas of cancer research [50]. Potential chemopreventive
agents may function by different mechanisms one of
which involves the induction of phase II detoxifying en-
zymes [55]. With regards to this, C. zeyheri can be a po-
tential chemopreventive agent as a result of the inductive
effects of the aqueous extract on the mammalian GSTs.
No alterations in organ/body weight ratios were ob-
served between the animals administered with the plant
extract compared to the control animals. This indicated
that there were no significant weight changes of both
the organ weight as well as the weight of the animals in
general, upon treatment with the plant extract. From
these results, it may be concluded that there was no in-
jury that occurred to the organs when the animals were
treated with the plant extract. A change in body or in-
ternal organ weight is an important index on the adverse
side effects of a chemical compound, including a plant
extract. A gain in weight by animals during an experi-
mental period may be an indication that the plant ex-
tract did not hamper the growth of the animals, whilst a
reduced weight of organs, could be as a consequence of
leakage of cytosolic enzymes into the extracellular fluid
serum. A decrease in the overall body weight of the ani-
mal is usually a clear indication of toxicity [56]. With
regards to this, C. zeyheri did not have any toxic effects
on the rats.
The medicinal uses of extracts from P. curatellifolia
plant are numerous. The plant has been used for wound
healing and skin problems, treatment of malaria, typhoid
fever, fracture and gastrointestinal disorders, while theleaf and bark extracts are deployed in the treatment of
pneumonia, eye and ear diseases, and the roots for treat-
ment of cataracts and ear pain [57] and liver disorders.
The seeds of P. curatellifolia exert a reduction in the
plasma glucose, and the level of low density lipoprotein
thus they have anti-diabetic properties. P. curatellifolia
seeds also have antioxidant properties that play a major
role in ameliorating secondary complications resulting
from oxidative damage in diabetes [58]. Due to its many
uses in traditional medical practices it is of importance
to determine the effects of the extracts from this plant
on liver and kidney glutathione transferases. The aque-
ous extract of P. curatellifolia had a dose-dependent in-
creasing effect on the liver protein content, especially at
the highest dose in the treated rats. However, this could
not be related to the decrease in GST activity in the
same organ. In a study by Hayeshi et al., [59] most of
the compounds from plant extracts they used did not
show inhibitory activity towards human GSTs and they
suggested that the target of the compounds in vivo were
particular resistance proteins in the cell. This might have
also have been the case with the P. curatellifolia ethano-
lic leaf extract used in this present study instead of it tar-
geting the GST enzymes. Another explanation for the
differences in the performance of GSTs from the livers
and kidneys could be because the inhibition of GSTs is
substrate-dependent as shown by the inhibition of hu-
man recombinant GSTs by antimalarials [60].
The inhibition of GSTs has been extensively studied
in vitro and the following compounds from plants have
been found to be inhibitors of the enzymes: tannic acid,
thonningianin A, cibacron blue, hematin, ethacrynic
acid, ellagic acid, ferulic acid, caffeic acid, stilbene, quer-
cetin, chlorogenic acid and curcumin have been long
reported by many researchers [61–64]. Ethacrynic acid
binds to the H-site of GSTs but has low affinity for the
enzyme, and conjugated with GSH, it is easily excreted
from the cell. Therefore, the aqueous extracts may have
high levels of these as an increase in the dose caused
increased enzyme inhibition also.
From the in vitro results obtained in this study, the
ethanol extracts was effective in the inhibition of rat
liver GSTs than the aqueous extraction. This effect was
confirmed by the IC50 values. The half maximum inhibi-
tory concentration value (IC50) is a measure of the
effectiveness of a compound in inhibiting a biological
process or biological function by 50 %. The ethanol
extract of this plant exhibited GST inhibitory activity in
the liver with an IC50 value of 12 μg/mL and for the
aqueous extract the value was 24 μg/mL. The IC50 value
of ethacrynic acid, a standard GST inhibitor was found
to be 10 μg/mL. This data suggested that the ethanolic
extract of P. curatellifolia contained some bioactive
compounds that inhibited liver GSTs activity in vitro
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IC50 values of P. curatellifolia ethanol extracts on the kid-
ney GSTs and of the aqueous extracts on both the liver
and the kidney GSTs were higher than those of ETA, a
standard GST inhibitor indicating that this extract was an
effective inhibitor. GST Sigma (hematopoietic prostaglan-
din D2 synthase H-PGDS,) is involved in inflammation by
its role in the isomerisation of PGH2 to produce PGD2,
which is an allergic mediator and promotes the inflamma-
tory process [64]. H-PGDS is, thus, a target for the design
of anti-inflammatory and anti-allergic drugs. Thus, the in-
hibition of GSTs by P. curatellifolia may validate its use
for the treatment of aches and inflammation [21].
P. curatellifolia leaf extracts showed significant inhib-
ition of GSTs in vivo. The effects observed in vitro may
differ from those effects observed in vivo [65]. Discrep-
ancies between in vitro and in vivo results have been de-
scribed elsewhere for antioxidants such as ellagic acid
and curcumin that are in vitro inhibitors, but in vivo in-
ducers of GSTs [66]. The inhibition might be due to the
presence of compounds which decrease the expression
of GSTs in vivo which does not occur in vitro [67]. The
difference between the in vivo and in vitro effects of
plant extracts on GSTs may have been because the in-
hibition of the enzyme is a time-dependent reaction that
needs longer periods to be observed or could be due to
formation of metabolites that do not have inhibitory ac-
tivity. Thus, the decreased GST activity in vivo correlates
to the observed inhibition in vitro and this may suggest
that the parent phytochemicals in the extracts and not
metabolites may be responsible for the inhibitory effects
observed in vivo.
Adverse interactions between drugs and herbs have
been reported in many studies [29, 68]. The mechanisms
of interactions have been reported to be due to the me-
tabolism of different drugs by the same enzyme system.
Nakajima et al., [69] proposed that the interaction be-
tween the anticoagulant warfarin and indomethacin was
because they are metabolized by the same enzyme sys-
tem CYP2C9 thus, resulting in a metabolic interaction.
It has been shown that about 98 % of HIV patients in
Zimbabwe use at least one herbal drug together with
their antiretroviral therapies [68]. Therefore, the present
study demonstrates that there could be significant herb-
drug interactions if P. curatellifolia leaf extracts are co-
administered with other synthetic conventional drugs
such as anticancer or anti-HIV drugs. For anti HIV
drugs, there would be a significant failure in reducing
the viral loads in patients resulting in increased mortality
of patients. For anticancer compounds the metabolism
of such drugs as cisplatin, busulfan, chlorambucil, cyclo-
phosphamide, melphalan and thiotepa by GSTs would
be inhibited by P. curatellifolia extracts leading to de-
creased plasma concentrations of the drugs. In the endthis has the effect of increasing the development of drug
resistant cancers. This is because drug interactions
caused by metabolic processes are regarded as the most
important factors that affect the concentrations of drugs
in the body [70]. Moreover, the GSTs inhibitory effects
of P. curatellifolia extracts could be of significant im-
portance in drug-resistant neoplasia as over-expression
of GSTs in tumor cell lines is responsible for their resist-
ance to certain chemotherapeutic drugs [71, 72]. There-
fore, this means that the use of inhibitors to modulate
the activity of GSTs during chemotherapy are a promis-
ing strategy in the battle against multi-drug resistance
that could result in enhanced therapeutic efficiency of
anticancer compounds.
It was also noted that different solvents had an effect
on the activities of GSTs. Corn oil which was used as a
vehicle for the ethanol extract was shown to increase the
activity of GSTs when compared with animals given sa-
line. Saline was shown to alter the activities of the GSTs,
depending on whether it was the liver or kidneys. GST
activities have been noted to be very high in the liver
and less in the extra hepatic organs [73]. Corn oil has
been reported to increase the levels of GSTs in rats
when compared to animals that were not treated [74]. It
is possible the observed effects are due to the different
vehicles which were used for the extracts in addition to
the effects of the extracts themselves. However, in this
study, it is important to note that when comparisons of
GST activities were performed, these were determined
on animals given the same vehicle for the extracts and,
therefore, cancelling out the effects of corn oil.
When drugs are given orally, they are transported to
the liver where biotransformation reactions take place.
Plant derived phytochemicals when administered in vivo,
have been shown to induce xenobiotic metabolism en-
zymes including glutathione transferases via the antioxi-
dant responsive element [75]. In this study, the effects C.
zeyheri observed in vivo were dependent on the type of
whether the extract was from the aqueous extract (saline
as a vehicle) or ethanol extract (corn oil as a vehicle).
The aqueous extract group showed increased GST activ-
ity regardless of whether the enzyme source was the kid-
ney or liver. In vitro, the opposite was observed and
there was decreased GST activity upon incubation with
the aqueous extracts. It seems, therefore, that whilst the
aqueous extract of C. zeyheri had inductive effects
in vivo, in vitro there was decreased activity. This sug-
gests that the extracts themselves or some metabolites
may have increased the activity of GSTs directly or indir-
ectly (inductive effect). Azizi et al., [76], showed similar
results to our study as they found that the Mitragyna
speciose leaf extract had different effects on GST activity
in vivo and in vitro. In their study, they found that there
was concentration-dependent inhibition of GST activity
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GST activity. Natural dietary compounds have been
shown to induce Phase II detoxifying enzymes via gene
activation through the Nuclear factor-erythroid 2-related
factor (Nrf2) -antioxidant response (ARE) pathway [75].
Conclusions
In summary, C. zeyheri extracts, have an inductive effect
on GST activity in vivo when administered in aqueous
solution but inhibited GST when administered as an
ethanol extracts. P. curatellifolia inhibited liver GSTs
in vivo when administered as an aqueous solution. Both
extracts inhibited GST activity in vitro suggesting that
the effects observed increases observed in vivo could be
due to the extracts or their metabolites acting on the in-
ductive system of the cells to increase the levels of the
enzymes. Induction of GSTs would be cytoprotective
against the toxic effects electrophilic chemicals but po-
tentially dangerous outcomes may occur if the activity of
GSTs in scavenging electrophilic metabolites is inhibited
by these plant species. The inhibition of GSTs by these
plant extracts may support their uses in the treatment of
fever, pain and inflammation as these enzymes are in-
volved in endogenous activities that produce certain
physiological products including pain mediators. There
is need to carry out further studies to isolate the bio-
active compounds responsible for inhibiting GSTs and
identify their structures.
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